How Bleeding Affects Delirium in Older Patients With Hip Fractures: The IMPROVE-HIP Study

NCT06938789 — Not applicable, Recruiting, 198 participants, University of Aarhus

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

The Impact of Bleeding on Delirium Outcomes in Older Patients With Hip Fractures: A Single-Blind, Randomized Controlled Trial - The IMPROVE-HIP Study

RegistryNCT06938789
StatusRecruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, prevention
Enrollment198 (Estimated)
SponsorUniversity of Aarhus (Other); collaborators: Gødstrup Hospital, Aarhus University Hospital
ConditionsBleeding, Hip Fracture, Delirium - Postoperative
InterventionsBlood Transfusion, Standard care (Other)
Datesstart 2025-04-24, primary completion 2026-12-31 (estimated), completion 2027-06-01 (estimated), first posted 2025-04-22, last updated 2026-05-22
Locations2 sites in Denmark

Related Papers Related Patents Related Grants Related Experts
All trials for Bleeding All trials for Hip Fracture All trials of Blood Transfusion All trials of Standard care

-Summary

The goal of this clinical trial is to investigate whether early detection of bleeding and prompt blood transfusions can help prevent delirium in patients aged 75 and older who are admitted to the hospital with hip fractures. The main question the trial aims to answer is:

Do patients aged 75 and older with hip fractures benefit from earlier treatment of anemia (low blood count) to reduce the risk of delirium?

Researchers will compare early diagnosis and treatment of bleeding with standard care to determine if it helps lower the risk of developing delirium.

Participants will:

Undergo blood tests, have their vital signs monitored, and be screened for delirium three times a day for the first 48 hours after surgery.

Receive blood transfusions promptly if their hemoglobin levels fall below a specified threshold.

Attend a follow-up visit at 30 days to assess cognitive function and overall quality of life.

Attend another follow-up at 90 days to evaluate hospital readmissions and survival.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Immediate Transfusion StrategyActive comparatorOther: Blood TransfusionVital parameters, delirium screening, and blood samples are collected three times a day. If the hemoglobin level falls below the predefined threshold, red blood cell transfusion is administered without delay (within 4 hours).
Standard Care with Delayed Hemoglobin analysisPlacebo comparatorOther: Standard careThe patients recieve standard care. To maintain patient blinding vital parameters, delirium screening, and blood samples are collected three times a day, just as in the intervention arm, however, hemoglobin analysis is delayed to avoid influencing transfusion decisions.
  • Blood Transfusion (Other): Blood transfusion is given without delay (within 4 hours) in case of hemoglobin below our threshold.
  • Standard care (Other): These patients recieve our standard care including blood transfusion as usual. Vital parameters and delirium screening are collected three times a day.

+Outcome measures

Primary outcomes

  • Number of Participants with Delirium [From enrollment to 48 hours after surgery]: Occurence of delirium will be evaluted using screening methods three times a day.

Secondary outcomes

  • Change from baseline in Quality of Life [Will be evaluated at the 30 day follow-up]: The overall Quality of life will be assed by the Overall Quality of life Depression List (OQoL-DL). It will be used to asses patients in both groups at the 30 day follow-up.
  • Cognitive status [Will be evaluated at the 30 day follow-up.]: Short Portable Mental Status Questionnaire (SPMSQ). Sum score 0-10, higher scores indicates cognitive impariment. The SPMSQ will be used to assess cognitve status in patients in both groups at follow-up.
  • Readmission rate [Within 90 days after surgery]: Readmission within 90 days after surgery. Readmission is defined as any uplanned, acute rehospitalisation in this period.
  • 90-day mortality [90 days after surgery.]: Mortality within the first 90-days after surgery.

+Eligibility

Sex: All, ages: 75 Years to any

Inclusion Criteria:

* Hip fracture

Exclusion Criteria:

* Pathological hip fracture
* Periprosthtic fracture
* Unable to speak or understand Danish
* Does not wish to recieve blood transfusion
* If the investigator finds the patient unable to cooperate to the study (e.g. in case of severe dementia and externalizing behaviour)

+Locations (2)

FacilityCityCountryStatus
Aarhus University HospitalAarhus, Central JutlandDenmarkNot yet recruiting
Gødstrup Hospital, Department of internal medicineHerning, Central JutlandDenmarkRecruiting